{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:19:37Z","timestamp":1790522377601,"version":"4.1.0"},"reference-count":97,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/med.0b013e32832afd4d","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T01:51:40Z","timestamp":1294969900000},"page":"224-231","source":"Crossref","is-referenced-by-count":106,"title":["Androgens and polycystic ovary syndrome"],"prefix":"10.1097","volume":"16","author":[{"given":"Vicki","family":"Nisenblat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20211004","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1992"},{"key":"R2-6-20211004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"R3-6-20211004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R4-6-20211004","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1472-6483(10)60902-9","article-title":"The ESHRE\/ASRM consensus on polycystic ovary syndrome (PCOS)-an extended critical analysis","volume":"14","author":"Geisth\u00f6vel","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"R5-6-20211004","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-6-20211004","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2265.2007.03053.x","article-title":"Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia","volume":"68","author":"Cho","year":"2008","journal-title":"Clin Endocrinol(Oxf)"},{"key":"R7-6-20211004","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.steroids.2008.05.002","article-title":"Testosterone and estradiol assays: current and future trends","volume":"73","author":"Demers","year":"2008","journal-title":"Steroids"},{"key":"R8-6-20211004","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-6-20211004","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1515\/CCLM.2007.031","article-title":"Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome","volume":"45","author":"Hahn","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"R10-6-20211004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/humupd\/dmm038","article-title":"In vitro bioassays for androgens and their diagnostic applications","volume":"14","author":"Roy","year":"2008","journal-title":"Hum Reprod Update"},{"key":"R11-6-20211004","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1447-0756.2007.00507.x","article-title":"Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?","volume":"33","author":"Vural","year":"2007","journal-title":"Obstet Gynaecol Res"},{"key":"R12-6-20211004","doi-asserted-by":"crossref","first-page":"398.e1","DOI":"10.1016\/j.ajog.2006.12.009","article-title":"Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters","volume":"196","author":"Goodarzi","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R13-6-20211004","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1007\/s00125-007-0831-9","article-title":"Brothers of women with polycystic ovary syndrome are characterized by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects","volume":"50","author":"Billargeon","year":"2007","journal-title":"Diabetologia"},{"key":"R14-6-20211004","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1210\/jc.2008-0369","article-title":"Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries","volume":"93","author":"Franks","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-6-20211004","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2337\/dc07-2190","article-title":"Metabolic phenotype in the brothers of women with polycystic ovary syndrome","volume":"31","author":"Sam","year":"2008","journal-title":"Diabetes Care"},{"key":"R16-6-20211004","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/jc.2007-1958","article-title":"Hyperandrogenism and hyperinsulenism in children of women with PCOS: a controlled study","volume":"93","author":"Kent","year":"2008","journal-title":"J Clin Endocinol Metab"},{"key":"R17-6-20211004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-992919","article-title":"Looking for polycystic ovary syndrome genes: rational and best strategy","volume":"26","author":"Goodarzi","year":"2008","journal-title":"Semin Reprod Med"},{"key":"R18-6-20211004","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/GRF.0b013e3180305f7c","article-title":"Genetics of polycystic ovarian syndrome","volume":"50","author":"Nam","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"R19-6-20211004","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ncpendmet0400","article-title":"The genetics of the polycystic ovary syndrome","volume":"3","author":"Urbanec","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R20-6-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2007\/49109","article-title":"The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-gamma.","volume":"2007","author":"Unluturk","year":"2007","journal-title":"PPAR Res"},{"key":"R21-6-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399408000598","article-title":"Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications","volume":"10","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"R22-6-20211004","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/me.2006-0303","article-title":"StAR search: what we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import","volume":"21","author":"Miller","year":"2007","journal-title":"Mol Endocrinol"},{"key":"R23-6-20211004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000160911","article-title":"Insulin modulation of luteinizing hormone secretion in normal female volunteers and lean polycystic ovary syndrome patients","volume":"89","author":"Moret","year":"2009","journal-title":"Neuroendocrinology"},{"key":"R24-6-20211004","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1472-6483(10)60140-X","article-title":"LH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo\/amenorrhoea","volume":"16","author":"Hendriks","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"R25-6-20211004","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.fertnstert.2007.09.016","article-title":"Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome","volume":"90","author":"Moran","year":"2008","journal-title":"Fertil Steril"},{"key":"R26-6-20211004","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-2007-984741","article-title":"Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty","volume":"25","author":"Blank","year":"2007","journal-title":"Semin Reprod Med"},{"key":"R28-6-20211004","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1210\/jc.2006-1678","article-title":"Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome","volume":"92","author":"Gambineri","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-6-20211004","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/humrep\/den273","article-title":"Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome","volume":"23","author":"Ahmed","year":"2008","journal-title":"Hum Reprod"},{"key":"R30-6-20211004","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/jc.2007-2664","article-title":"Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome","volume":"93","author":"Wachs","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-6-20211004","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.fertnstert.2007.01.032","article-title":"Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria","volume":"88","author":"Shroff","year":"2007","journal-title":"Fertil Steril"},{"key":"R33-6-20211004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2265.2007.02849.x","article-title":"Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidemia in adolescent girls with polycystic ovary syndrome","volume":"67","author":"Demirel","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R35-6-20211004","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/09513590802234253","article-title":"Body fat composition and distribution in women with polycystic ovary syndrome","volume":"24","author":"Cosar","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"R36-6-20211004","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2008.02.091","article-title":"The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance","volume":"89","author":"Bremer","year":"2008","journal-title":"Fertil Steril"},{"key":"R37-6-20211004","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1429.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"1135","author":"Blank","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R38-6-20211004","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jsbmb.2008.03.014","article-title":"Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome","volume":"109","author":"Diamanti-Kandarakis","year":"2008","journal-title":"J Steroid Biochem and Molecular Biol"},{"key":"R39-6-20211004","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.metabol.2008.05.002","article-title":"Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation","volume":"57","author":"Asagami","year":"2008","journal-title":"Metabolism"},{"key":"R40-6-20211004","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.fertnstert.2006.12.055","article-title":"Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity","volume":"88","author":"Baillargeon","year":"2007","journal-title":"Fertil Steril"},{"key":"R41-6-20211004","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"R42-6-20211004","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2006-1705","article-title":"Atherogenic lipoprotein phenotype and low density lipoproteins size and subclasses in women with polycystic ovary syndrome","volume":"92","author":"Berneis","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-6-20211004","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/EJE-07-0515","article-title":"Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome","volume":"158","author":"Cupisti","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"R44-6-20211004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-2007-970163","article-title":"Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS","volume":"115","author":"Cupisti","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R45-6-20211004","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2006-2002","article-title":"Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre and early pubertal obese girls","volume":"92","author":"McCartney","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-6-20211004","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.fertnstert.2007.04.043","article-title":"Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels","volume":"89","author":"Panidis","year":"2008","journal-title":"Fertil Steril"},{"key":"R47-6-20211004","first-page":"210","article-title":"Early onset adiposity: a pathway to polysystic ovary syndrome in adolescence?","volume":"6","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Hormones"},{"key":"R48-6-20211004","first-page":"35","article-title":"Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome","volume":"32","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Minerva Endocrinol"},{"key":"R49-6-20211004","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1210\/jc.2008-0714","article-title":"Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial","volume":"93","author":"Mai","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R50-6-20211004","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11154-007-9054-0","article-title":"The adrenal and polycystic ovary syndrome","volume":"8","author":"Yildiz","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"R52-6-20211004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF03347408","article-title":"Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes","volume":"30","author":"Carmina","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"R53-6-20211004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000134831","article-title":"Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome","volume":"13","author":"Abbott","year":"2008","journal-title":"Endocr Dev"},{"key":"R54-6-20211004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11154-008-9099-8","article-title":"Nonhuman primates as models for human adrenal androgen production: function and dysfunction","volume":"10","author":"Abbot","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"R55-6-20211004","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.fertnstert.2006.05.045","article-title":"Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters","volume":"86","author":"Yildiz","year":"2006","journal-title":"Fertil Steril"},{"key":"R56-6-20211004","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1210\/jc.2005-2222","article-title":"Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R57-6-20211004","first-page":"237","article-title":"Genes for enzymes regulating DHEA sulfonation are associated with levels of DHEA-sulfate in polycystic ovary syndrome","volume":"13","author":"Goodarzi","year":"2007","journal-title":"Mol Hum Reprod"},{"key":"R58-6-20211004","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/jc.2008-0403","article-title":"Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome","volume":"93","author":"Goodarzi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R59-6-20211004","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1248\/bpb.30.2091","article-title":"Comparison of basal gene expression and induction CYP3A in HepG2 and human fetal liver cells","volume":"30","author":"Maruyama","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"R60-6-20211004","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1152\/ajpendo.90208.2008","article-title":"Transient prenatal androgen exposure produces metabolic syndrome in adult female rats","volume":"295","author":"Demissie","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R61-6-20211004","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1152\/ajpendo.00605.2006","article-title":"Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat","volume":"292","author":"Erhuma","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R62-6-20211004","first-page":"1660","article-title":"Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype","volume":"91","author":"Urbanek","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-6-20211004","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/humrep\/dem382","article-title":"The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome","volume":"23","author":"Xita","year":"2008","journal-title":"Hum Reprod"},{"key":"R64-6-20211004","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1530\/EJE-07-0905","article-title":"The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype","volume":"158","author":"Xita","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"R65-6-20211004","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/humrep\/del457","article-title":"The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome","volume":"22","author":"Ferk","year":"2007","journal-title":"Hum Reprod"},{"key":"R66-6-20211004","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.fertnstert.2007.10.030","article-title":"Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome","volume":"90","author":"Kim","year":"2008","journal-title":"Fertil Steril"},{"key":"R67-6-20211004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/09513590802210865","article-title":"Androgen receptor gene CAG repeat length in women with metabolic syndrome","volume":"24","author":"Jaaskelainen","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"R68-6-20211004","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2265.2008.03298.x","article-title":"Transient anomalies in genital appearance in some extremely preterm female infants may be the result of foetal programming causing a surge in LH and the over activation of the pituitary-gonadal axis","volume":"69","author":"Greaves","year":"2008","journal-title":"Clin Endocrinol"},{"key":"R69-6-20211004","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1210\/en.2007-0305","article-title":"Postnatal testosterone exposure results in insulin resistance, enlarged mesenteric adipocytes, and an atherogenic lipid profile in adult female rats: comparisons with estradiol and dehydrotestosterone","volume":"148","author":"Alexanderson","year":"2007","journal-title":"Endocrinology"},{"key":"R70-6-20211004","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1210\/en.2007-0168","article-title":"A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome","volume":"148","author":"Manneras","year":"2007","journal-title":"Endocrinology"},{"key":"R71-6-20211004","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.lfs.2007.02.013","article-title":"Impairment in insulin sensitivity after early androgenisation in the postpubertal female rat","volume":"80","author":"Perello","year":"2007","journal-title":"Life Sci"},{"key":"R72-6-20211004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1095\/biolreprod.107.064089","article-title":"Androgen actions and the ovary","volume":"78","author":"Walters","year":"2008","journal-title":"Biol Reprod"},{"key":"R73-6-20211004","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1677\/joe.1.07070","article-title":"Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes in women","volume":"192","author":"Corbould","year":"2007","journal-title":"J Endocrinol"},{"key":"R74-6-20211004","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"key":"R75-6-20211004","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1210\/en.2007-1527","article-title":"Pathways leading to phosphorylation of p450c17 and to the posttranslational regulation of androgen biosynthesis","volume":"149","author":"Tee","year":"2008","journal-title":"Endocrinology"},{"key":"R76-6-20211004","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1210\/jc.2006-1697","article-title":"Stage-specific expression of androgen receptor, follicle-stimulating hormone receptor and antimullerian hormone type II receptor in single, isolated, human preantral follicules: relevance to polycystic ovaries","volume":"92","author":"Rice","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R77-6-20211004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/REP-07-0172","article-title":"Testosterone selectively increases primary follicles in ovarian cortex grafted onto embryonic chick membranes: relevance to polycystic ovaries","volume":"136","author":"Qureshi","year":"2008","journal-title":"Reproduction"},{"key":"R78-6-20211004","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1210\/en.2007-0248","article-title":"Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and infertility","volume":"148","author":"Walters","year":"2007","journal-title":"Endocrinology"},{"key":"R79-6-20211004","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1210\/jc.2006-2123","article-title":"Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis","volume":"92","author":"Wood","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R80-6-20211004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","volume":"66","author":"Barber","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R81-6-20211004","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/humrep\/den263","article-title":"Cardio metabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome","volume":"23","author":"Cussons","year":"2008","journal-title":"Hum Reprod"},{"key":"R82-6-20211004","doi-asserted-by":"crossref","first-page":"670e1","DOI":"10.1016\/j.ajog.2008.01.037","article-title":"Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria","volume":"198","author":"Kauffman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R83-6-20211004","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.2007.02954.x","article-title":"Unraveling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS","volume":"67","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R84-6-20211004","first-page":"39","article-title":"Int Prevalence of symptoms associated with polycystic ovary syndrome","volume":"102","author":"Lindholm","year":"2008","journal-title":"J Gynaecol Obstet"},{"key":"R85-6-20211004","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/dmrr.872","article-title":"Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?","volume":"24","author":"Corbould","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"R86-6-20211004","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1210\/jc.2008-1198","article-title":"Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome","volume":"93","author":"Rossi","year":"2008","journal-title":"J Clin Endocrin Metab"},{"key":"R87-6-20211004","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/HYPERTENSIONAHA.106.083972","article-title":"Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome","volume":"49","author":"Chen","year":"2007","journal-title":"Hypertension"},{"key":"R88-6-20211004","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.metabol.2008.02.012","article-title":"Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women","volume":"57","author":"Maturana","year":"2008","journal-title":"Metab Clin Experiment"},{"key":"R89-6-20211004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.AOG.0000296657.41236.10","article-title":"Vascular risk in young women with polycystic ovary and polycystic ovary syndrome","volume":"111","author":"Battaglia","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R91-6-20211004","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1210\/jc.2007-1343","article-title":"Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis","volume":"92","author":"Shroff","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R92-6-20211004","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1093\/humrep\/dem324","article-title":"Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome","volume":"22","author":"Luque-Ram\u00edrez","year":"2007","journal-title":"Hum Reprod"},{"key":"R93-6-20211004","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of Metformin, Oral Contraceptives and lifestyle modification, on Polycystic Ovary Syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials","volume":"93","author":"Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R94-6-20211004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/011542650802300163","article-title":"Polycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference?","volume":"23","author":"Liepa","year":"2008","journal-title":"Nutr Clin Pract"},{"key":"R95-6-20211004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00404-007-0401-x","article-title":"The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome","volume":"277","author":"Gul","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"R96-6-20211004","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.atherosclerosis.2007.03.002","article-title":"The administration of estrogens, combined with antiandrogens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome","volume":"196","author":"Charitidou","year":"2008","journal-title":"Atherosclerosis"},{"key":"R97-6-20211004","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1210\/jc.2007-0842","article-title":"Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment","volume":"93","author":"Heutling","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R98-6-20211004","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/jc.2006-2684","article-title":"Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess","volume":"92","author":"Ib\u00e1\u00f1ez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R99-6-20211004","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/09513590802217027","article-title":"Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome","volume":"24","author":"Wu","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"R100-6-20211004","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2006-1988","article-title":"Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial","volume":"92","author":"Banaszewska","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"R102-6-20211004","first-page":"CD005552","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R103-6-20211004","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review","volume":"22","author":"Costello","year":"2007","journal-title":"Hum Reprod"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01266029-200906000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:50:00Z","timestamp":1786042200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01266029-200906000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e32832afd4d","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}